Fertility Supplement Market Report 2025

This Fertility Supplement market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The fertility supplement market size has grown strongly in recent years. It will grow from $1.79 billion in 2024 to $1.94 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth during the historic period can be attributed to factors such as rising healthcare costs, the increasing trend of women delaying pregnancies, growing popularity of customized nutrition, a higher demand for natural products, and an increasing preference for organic supplements.

The fertility supplement market size is expected to see strong growth in the next few years. It will grow to $2.63 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The expected growth in the forecast period is driven by the rising incidence of infertility, a growing demand for natural ingredients, increased alcohol consumption and smoking, a higher number of obese individuals, and rising stress levels. Key trends during this period include the integration of telehealth, strategic collaborations, specialized supplements, advancements in genetic testing, and progress in medical technology.

The growing prevalence of infertility is expected to drive the expansion of the fertility supplement market. Infertility is defined as the inability to conceive after one year of regular, unprotected intercourse or the inability to carry a pregnancy to term. Factors such as delayed childbearing, lifestyle changes, environmental toxins, rising obesity rates, and higher stress levels contribute to the increasing prevalence of infertility. Fertility supplements are essential for treating infertility as they provide key vitamins, minerals, and nutrients that support reproductive health, hormone balance, and overall fertility function. For example, in July 2024, the Human Fertilization and Embryology Authority, a UK-based public body, reported that licensed fertility clinics in the UK conducted nearly 77,000 fresh and frozen embryo transfer IVF cycles for 52,500 patients in 2022. Over 90% of these patients underwent treatment with a partner, involving approximately 100,000 individuals. As a result, the rising incidence of infertility is contributing to the growth of the fertility supplement market.

Companies in the fertility supplement market are increasingly focusing on developing personalized products, such as natural fertility supplements, which offer a holistic approach to enhancing reproductive health. These products utilize plant-based ingredients and essential nutrients, with fewer synthetic chemicals and potential side effects compared to traditional treatments. Natural fertility supplements are dietary products made from plant-based ingredients, vitamins, and minerals, aiming to support hormonal balance, egg quality, and overall reproductive health. For example, in November 2024, Nestlé, a Switzerland-based health and wellness company, launched the Materna Pre and Materna Nausea solutions. The Materna range now includes two new products designed to support women’s fertility and alleviate common pregnancy-related symptoms such as nausea and vomiting. By incorporating natural ginger and vitamin B6, the new Materna Nausea product has been scientifically proven to reduce the severity of nausea and vomiting during pregnancy. This expansion highlights Materna’s commitment to providing women with personalized, science-based nutritional solutions before conception, throughout pregnancy, and after childbirth to improve health outcomes for both mothers and their babies.

In March 2023, Sumitovant Biopharma Ltd., a US-based pharmaceutical company, acquired Myovant Sciences Ltd. for $1.7 billion. This acquisition allows Sumitomo Pharma to combine the expertise of Sumitovant and Myovant to accelerate the development of innovative therapies. The integration aims to maximize the potential of ORGOVYX and MYFEMBREE, expand the reach of differentiated treatments, and advance ongoing clinical programs. Myovant Sciences Ltd., based in the UK, specializes in developing fertility supplements.

Major players in the fertility supplement market are GNC Holdings LLC, Bharat Serums And Vaccines Limited, Orthomol Holding, Vitabiotics Ltd., TTK Healthcare Ltd., FUJIFILM Irvine Scientific, Lenus Pharma GesmbH, Innovamed Ltd., AdvaCare Pharma, Prega News, Theralogix LLC, Fairhaven Health LLC, Coast Science LLC, Bionova Inc., Extreme V Inc., Crown Fertility, YadTech Inc., Xena Bio Herbals Pvt. Ltd., Pillar Healthcare Ltd., Zenith Nutrition Co, Amitamin, Eu Natural Inc., Proxeed, Fairhaven Health LLC, and Babystart Ltd.

North America was the largest region in the fertility supplement market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in fertility supplement report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the fertility supplement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Fertility supplements are dietary products designed to support reproductive health and enhance fertility. These supplements typically contain vitamins, minerals, herbs, and other natural ingredients that help promote hormonal balance, egg quality, sperm health, and overall reproductive function. They are often used by individuals who are trying to conceive or dealing with fertility-related issues.

The main forms of fertility supplements include tablets, capsules, powders, liquids, soft gels, and others. Tablets are solid, compressed forms of the supplement that are easy to dose and commonly used. They may contain a mix of both natural and synthetic ingredients or solely natural compounds. These supplements are distributed through various channels, including over-the-counter, prescribed, and other means, and are used by both men and women.

The fertility supplement market research report is one of a series of new reports that provides fertility supplement market statistics, including fertility supplement industry global market size, regional shares, competitors with a fertility supplement market share, detailed fertility supplement market segments, market trends and opportunities, and any further data you may need to thrive in the fertility supplement industry. This fertility supplement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The fertility supplement market consists of sales of prenatal vitamins, ovulation support supplements, PCOS treatment supplements, and sperm health supplements. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.